Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência.
Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Aristospan (triamcinolone hexacetonide) — a treatment for juvenile idiopathic arthritis (JIA) and similar disorders — has been approved for public reimbursement in Canada, after the completion of price negotiations with the ... Read more
The U.S. Food and Drug Administration (FDA) has approved starting a Phase 3 clinical trial testing Genentech‘s Actemra (tocilizumab) — a medicine approved for certain types of juvenile idiopathic arthritis ... Read more